Controversies in Stroke Care Webinar SeriesRedefining Exclusion/Inclusion Criteria
|
The Program
Significant knowledge and practice gaps exist across the continuum of stroke care. Stroke is highly preventable, yet nearly 800,000 strokes occur each year. Although effective treatments exist that could benefit up to 40 percent of stroke patients, fewer than 10 percent of stroke patients actually receive these treatments. Despite significant progress in understanding how to stimulate rehabilitation and recovery after stroke, nearly two-thirds of stroke survivors have disabilities that significantly impact their quality of life. The risk factors that lead to stroke have reached epidemic dimensions and treatment possibilities are being explored in a variety of directions. These developments have created a need to debate the many controversial issues in stroke care and reach clinical conclusions that drive better care for the at-risk population, stroke patients and stroke survivors.
Academic controversy is the instructional use of intellectual conflict to promote higher levels of learning. According to Johnson and Johnson, active engagement in academic controversy results in greater achievement and retention; higher quality reasoning, problem solving and decision making; more frequent creative insight; more thorough exchange of expertise; greater task involvement; and attitude change. Representation from a variety of experts arguing different views on efficacy can stimulate greater reflection and learning in areas of controversy. Participants in National Stroke Association’s Controversies in Stroke Care series will have the opportunity to discuss and debate these unresolved issues with leading world experts.
Program Goal
The goal of the Controversies in Stroke Care Webinar Series is to raise awareness among clinicians of the controversies surrounding stroke treatment and rehabilitation.
AMA Credit Designation
This activity has been approved for AMA PRA Category Credit(s)™.
Nursing Credit Designation
Nursing contact hours will be provided for this activity.
Disclaimer
The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Medical Education Resources, National Stroke Association and/or Genentech and Penumbra. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Medical Education Resources, National Stroke Association and/or Genentech and Penumbra. MER’s ANCC accreditation status does not imply endorsement by MER or ANCC of any commercial products displayed in conjunction with this activity. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.
Controversies in Stroke Care Webinar Series
 |
Redefining Inclusion/Exclusion Criteria for IV tPA Use |
|
Rehabilitation for Stroke Patients |
|
Acute Interventions |
The Controversies in Stroke Care webinar series is brought to you by an educational grant from Genentech, Inc. and Penumbra, Inc.
